Trial Profile
An Open-label, Randomized, Single-dose Crossover Study to Compare the Pharmacokinetics After the Administration of HCP1201 Tablet 500/10 mg and Coadministration of Metformin SR 500 mg and Rosuvastatin 10 mg in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Metformin/rosuvastatin (Primary) ; Metformin; Rosuvastatin
- Indications Hyperlipidaemia; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 06 Feb 2014 New source identified and integrated (Korean Clinical Trials Register)
- 06 Feb 2014 Status changed from active, no longer recruiting to completed as reported by Korean Clinical Trials Register
- 17 Dec 2013 New trial record